Nabriva Therapeutics Plc (NBRV) has 57 open-market insider trades by 16 insiders since 2017. The most active filer is HBM Healthcare Investments (Cayman) Ltd., 10% Owner.
| Name | Title | Tier | Trades | Value | Last Trade |
|---|---|---|---|---|---|
| HBM Healthcare Investments (Cayman) Ltd. | 10% Owner | — | 20 | $8.4M | 2017-09-14 |
| Vivo Capital VIII, LLC | 10% Owner | — | 1 | $996K | 2017-09-18 |
| Theodore R. Schroeder | CEO | — | 3 | $317K | 2023-01-29 |
| George Harrison Talbot | Dir | — | 5 | $130K | 2020-07-29 |
| Colin Broom M.D. | Dir | — | 7 | $116K | 2022-08-02 |
| Daniel D. Burgess | Dir | — | 3 | $103K | 2022-08-02 |
| Charles A. Rowland Jr. | Dir | — | 3 | $72K | 2022-08-01 |
| Robert Crotty | Secretary | — | 1 | $45K | 2021-08-31 |
| Stephen W. Webster | Dir | — | 3 | $39K | 2022-08-02 |
| Steven P. Gelone | Dir | — | 1 | $38K | 2023-01-29 |
| Insider | Title | Type | Value | Date |
|---|---|---|---|---|
| Mark Corrigan | Director | Sell | $2K | 2022-08-02 |
| Stephen W. Webster | Director | Sell | $1K | 2022-08-02 |
| Colin Broom M.D. | Director | Sell | $1K | 2022-08-02 |
| Daniel D. Burgess | Director | Sell | $2K | 2022-08-02 |
| Carrie L. Bourdow | Director | Sell | $1K | 2022-08-01 |
| Charles A. Rowland Jr. | Director | Sell | $2K | 2022-08-01 |
Companies that share insiders with NBRV, and sector peers with recent insider buying. Related by who files, not by how the stocks move.
| Theodore R. Schroeder | CEO | Buy | $114K | 2021-12-28 |
| J. Christopher Naftzger | General Counsel and Corp Sec | Buy | $4K | 2021-12-27 |
| Theodore R. Schroeder | CEO | Buy | $113K | 2021-09-14 |
| Daniel D. Burgess | Director | Sell | $1K | 2021-08-02 |
| Carrie L. Bourdow | Director | Sell | $932 | 2021-08-02 |
| Colin Broom M.D. | Director | Sell | $637 | 2021-08-02 |
| Colin Broom M.D. | Director | Sell | $7K | 2020-08-20 |
| Colin Broom M.D. | Director | Buy | $21K | 2019-08-30 |
| Theodore R. Schroeder | CEO | Buy | $90K | 2019-08-27 |